For example, METTL3, the catalytic core component of the m6A methyltransferase complex, is frequently upregulated in advanced cancers such as lung adenocarcinoma, hepatocellular carcinoma, pancreatic cancer, and colorectal carcinoma [60,61,62,63]. This evidence concerns the gene METTL3 and familial pancreatic carcinoma.